FANCI and ovarian carcinoma: Besides, the functions of the FANCI protein have been investigated in various cancers, and FANCI has also been proven to be regarded as a prognostic biomarker, given its high expression is associated with poor survival rate and therapeutic outcome in lung adenocarcinoma, cervical cancer, and ovarian cancer 11-13.